BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 8972869)

  • 1. Octamer independent activation of transcription from the kappa immunoglobulin germline promoter.
    Prabhu A; O'Brien DP; Weisner GL; Fulton R; Van Ness B
    Nucleic Acids Res; 1996 Dec; 24(23):4805-11. PubMed ID: 8972869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel upstream element compensates for an ineffectual octamer motif in an immunoglobulin V kappa promoter.
    Atchison ML; Delmas V; Perry RP
    EMBO J; 1990 Oct; 9(10):3109-17. PubMed ID: 2120037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.
    Shah PC; Bertolino E; Singh H
    EMBO J; 1997 Dec; 16(23):7105-17. PubMed ID: 9384588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A B-cell coactivator of octamer-binding transcription factors.
    Gstaiger M; Knoepfel L; Georgiev O; Schaffner W; Hovens CM
    Nature; 1995 Jan; 373(6512):360-2. PubMed ID: 7779176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the Ets family factor PU.1 in the activation of immunoglobulin promoters.
    Schwarzenbach H; Newell JW; Matthias P
    J Biol Chem; 1995 Jan; 270(2):898-907. PubMed ID: 7822329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oct proteins are qualitative rather than quantitative regulators of kappa transcription.
    Liberg D; Sigvardsson M; Leanderson T
    Mol Immunol; 1997 Oct; 34(14):979-86. PubMed ID: 9488048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration.
    Kemler I; Bucher E; Seipel K; Müller-Immerglück MM; Schaffner W
    Nucleic Acids Res; 1991 Jan; 19(2):237-42. PubMed ID: 2014164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerted repression of an immunoglobulin heavy-chain enhancer, 3' alpha E(hs1,2).
    Singh M; Birshtein BK
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4392-7. PubMed ID: 8633077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.
    Laurencikiene J; Deveikaite V; Severinson E
    J Immunol; 2001 Sep; 167(6):3257-65. PubMed ID: 11544313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter.
    Thévenin C; Lucas BP; Kozlow EJ; Kehrl JH
    J Biol Chem; 1993 Mar; 268(8):5949-56. PubMed ID: 7680653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time analysis of Oct protein-octamer interaction and transcription complex assembly.
    Malmborg AC; Johansson K; Sigvardsson M; Borrebaeck CA; Leanderson T
    Mol Immunol; 1995 Dec; 32(17-18):1429-42. PubMed ID: 8643112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An IgH enhancer that drives transcription through basic helix-loop-helix and Oct transcription factor binding motifs. Functional analysis of the E(mu)3' enhancer of the catfish.
    Cioffi CC; Middleton DL; Wilson MR; Miller NW; Clem LW; Warr GW
    J Biol Chem; 2001 Jul; 276(30):27825-30. PubMed ID: 11375977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
    Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
    EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an octamer-1 transcription factor binding site in the promoter of the mouse mu-opioid receptor gene.
    Liang Y; Carr LG
    J Neurochem; 1996 Oct; 67(4):1352-9. PubMed ID: 8858915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters.
    Pierani A; Heguy A; Fujii H; Roeder RG
    Mol Cell Biol; 1990 Dec; 10(12):6204-15. PubMed ID: 2123291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An essential octamer motif in the mb-1 (Igalpha) promoter.
    Malone CS; Patrone L; Wall R
    Mol Immunol; 2000 Apr; 37(6):321-8. PubMed ID: 11000405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extinction of an immunoglobulin kappa promoter in cell hybrids is mediated by the octamer motif and correlates with suppression of Oct-2 expression.
    Junker S; Pedersen S; Schreiber E; Matthias P
    Cell; 1990 May; 61(3):467-74. PubMed ID: 2110507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?
    Matthias P
    Semin Immunol; 1998 Apr; 10(2):155-63. PubMed ID: 9618761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.
    Schubart DB; Sauter P; Massa S; Friedl EM; Schwarzenbach H; Matthias P
    Nucleic Acids Res; 1996 May; 24(10):1913-20. PubMed ID: 8657574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel ubiquitous and cell type-specific factors that specifically recognize immunoglobulin heavy chain and kappa light chain promoters.
    Franke S; Scholz G; Scheidereit C
    J Biol Chem; 1994 Aug; 269(31):20075-82. PubMed ID: 8051094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.